• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRMT5 在恶性和转移性黑色素瘤中上调,并调节 MITF 和 p27(Kip1.)的表达。

PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.).

机构信息

Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.

出版信息

PLoS One. 2013 Sep 30;8(9):e74710. doi: 10.1371/journal.pone.0074710. eCollection 2013.

DOI:10.1371/journal.pone.0074710
PMID:24098663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3786975/
Abstract

Protein arginine methyltransferase-5 (PRMT5) is a Type II arginine methyltransferase that regulates various cellular functions. We hypothesized that PRMT5 plays a role in regulating the growth of human melanoma cells. Immunohistochemical analysis indicated significant upregulation of PRMT5 in human melanocytic nevi, malignant melanomas and metastatic melanomas as compared to normal epidermis. Furthermore, nuclear PRMT5 was significantly decreased in metastatic melanomas as compared to primary cutaneous melanomas. In human metastatic melanoma cell lines, PRMT5 was predominantly cytoplasmic, and associated with its enzymatic cofactor Mep50, but not STAT3 or cyclin D1. However, histologic examination of tumor xenografts from athymic mice revealed heterogeneous nuclear and cytoplasmic PRMT5 expression. Depletion of PRMT5 via siRNA inhibited proliferation in a subset of melanoma cell lines, while it accelerated growth of others. Loss of PRMT5 also led to reduced expression of MITF (microphthalmia-associated transcription factor), a melanocyte-lineage specific oncogene, and increased expression of the cell cycle regulator p27(Kip1). These results are the first to report elevated PRMT5 expression in human melanoma specimens and indicate this protein may regulate MITF and p27(Kip1) expression in human melanoma cells.

摘要

蛋白质精氨酸甲基转移酶 5(PRMT5)是一种 II 型精氨酸甲基转移酶,调节各种细胞功能。我们假设 PRMT5 在调节人类黑色素瘤细胞的生长中起作用。免疫组织化学分析表明,与正常表皮相比,PRMT5 在人类黑素细胞痣、恶性黑色素瘤和转移性黑色素瘤中显著上调。此外,与原发性皮肤黑色素瘤相比,转移性黑色素瘤中的核 PRMT5 显著减少。在人类转移性黑色素瘤细胞系中,PRMT5 主要位于细胞质中,并与酶辅因子 Mep50 相关,但与 STAT3 或细胞周期蛋白 D1 无关。然而,对无胸腺小鼠肿瘤异种移植的组织学检查显示 PRMT5 的核和细胞质表达不均匀。通过 siRNA 耗尽 PRMT5 抑制了一部分黑色素瘤细胞系的增殖,而加速了其他细胞系的生长。PRMT5 的缺失也导致小眼相关转录因子(MITF)的表达减少,MITF 是一种黑素细胞系特异性癌基因,细胞周期调节剂 p27(Kip1)的表达增加。这些结果首次报道了 PRMT5 在人类黑色素瘤标本中的表达升高,并表明该蛋白可能调节人类黑色素瘤细胞中的 MITF 和 p27(Kip1)表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/cf4f2690c7df/pone.0074710.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/dd7e6c1c75ab/pone.0074710.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/6d8108f630f8/pone.0074710.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/b67893736a9a/pone.0074710.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/cf4f2690c7df/pone.0074710.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/dd7e6c1c75ab/pone.0074710.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/6d8108f630f8/pone.0074710.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/b67893736a9a/pone.0074710.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2809/3786975/cf4f2690c7df/pone.0074710.g004.jpg

相似文献

1
PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.).PRMT5 在恶性和转移性黑色素瘤中上调,并调节 MITF 和 p27(Kip1.)的表达。
PLoS One. 2013 Sep 30;8(9):e74710. doi: 10.1371/journal.pone.0074710. eCollection 2013.
2
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.小眼畸形相关转录因子(Mitf)对Dia1的调控作用控制着黑色素瘤的增殖和侵袭能力。
Genes Dev. 2006 Dec 15;20(24):3426-39. doi: 10.1101/gad.406406.
3
Prognostic significance of cytoplasmic p27 expression in human melanoma.细胞质 p27 表达在人类黑色素瘤中的预后意义。
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2212-21. doi: 10.1158/1055-9965.EPI-11-0472. Epub 2011 Aug 9.
4
The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.正常及病理状态下皮肤、毛囊和黑素细胞痣中瞬时受体电位阳离子通道亚家族M成员1(TRPM1,褪黑素)mRNA表达与小眼畸形相关转录因子(MITF)及其他黑素生成相关蛋白的相关性
J Cutan Pathol. 2010 Apr;37 Suppl 1(Suppl 1):26-40. doi: 10.1111/j.1600-0560.2010.01504.x.
5
A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.小眼畸形相关转录因子调控的色素上皮衍生因子在黑色素瘤进展过程中的新作用。
Am J Pathol. 2015 Jan;185(1):252-65. doi: 10.1016/j.ajpath.2014.09.012. Epub 2014 Nov 6.
6
Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression.甲基osome蛋白50和蛋白激酶Cδ/ p38δ蛋白信号通过对p21Cip1基因表达的相反作用控制角质形成细胞增殖。
J Biol Chem. 2015 May 22;290(21):13521-30. doi: 10.1074/jbc.M115.642868. Epub 2015 Apr 7.
7
Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.突变型B-RAF信号传导和细胞周期蛋白D1调节人黑素瘤细胞中Cks1/细胞周期蛋白依赖性激酶调节亚基1介导的p27Kip1降解。
Oncogene. 2007 Feb 15;26(7):1056-66. doi: 10.1038/sj.onc.1209861. Epub 2006 Aug 21.
8
Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.靶向蛋白精氨酸甲基转移酶5通过下调β-连环蛋白抑制人肝癌生长。
J Transl Med. 2015 Nov 5;13:349. doi: 10.1186/s12967-015-0721-8.
9
SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.SHARPIN 通过调控蛋白精氨酸甲基转移酶 5 控制黑色素瘤生长。
J Clin Invest. 2018 Jan 2;128(1):517-530. doi: 10.1172/JCI95410. Epub 2017 Dec 11.
10
Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.精氨酸甲基转移酶 5 是一种潜在的癌蛋白,可上调 G1 周期蛋白/细胞周期依赖性激酶和磷脂酰肌醇 3-激酶/AKT 信号级联。
Cancer Sci. 2012 Sep;103(9):1640-50. doi: 10.1111/j.1349-7006.2012.02367.x. Epub 2012 Aug 8.

引用本文的文献

1
Current and Emerging Therapies for Targeting Protein Arginine Methyltransferases (PRMTs) in Cancer.用于靶向癌症中蛋白质精氨酸甲基转移酶(PRMTs)的当前及新兴疗法
Int J Mol Sci. 2025 Aug 16;26(16):7907. doi: 10.3390/ijms26167907.
2
PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5-KRAS Crosstalk.PRMT5抑制作为KRAS突变型结直肠癌的潜在策略:PRMT5-KRAS相互作用的下游介质
Curr Issues Mol Biol. 2025 Aug 18;47(8):665. doi: 10.3390/cimb47080665.
3
Regulation of RORα Stability through PRMT5-Dependent Symmetric Dimethylation.

本文引用的文献

1
UVB-induced melanocyte proliferation in neonatal mice driven by CCR2-independent recruitment of Ly6c(low)MHCII(hi) macrophages.UVB 诱导新生小鼠黑素细胞增殖,由 CCR2 非依赖性 Ly6c(low)MHCII(hi)巨噬细胞募集驱动。
J Invest Dermatol. 2013 Jul;133(7):1803-12. doi: 10.1038/jid.2013.9. Epub 2013 Jan 15.
2
The role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesis.核苷酸切除修复改变及UVB诱导的DNA损伤在黑色素瘤发生中的作用。
Int J Mol Sci. 2013 Jan 9;14(1):1132-51. doi: 10.3390/ijms14011132.
3
Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer.
通过PRMT5依赖的对称二甲基化对RORα稳定性的调控
Cancers (Basel). 2024 May 17;16(10):1914. doi: 10.3390/cancers16101914.
4
Genetic screen identified PRMT5 as a neuroprotection target against cerebral ischemia.遗传筛选鉴定 PRMT5 为脑缺血的神经保护靶标。
Elife. 2024 Feb 19;12:RP89754. doi: 10.7554/eLife.89754.
5
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma.PRMT5作为MYC扩增型髓母细胞瘤的潜在治疗靶点。
Cancers (Basel). 2023 Dec 15;15(24):5855. doi: 10.3390/cancers15245855.
6
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.PRMT5 抑制剂调节癌细胞中的 DNA 损伤修复途径,并提高对 PARP 抑制剂和化疗的反应。
Cancer Res Commun. 2023 Nov 6;3(11):2233-2243. doi: 10.1158/2767-9764.CRC-23-0070.
7
Citrullination and the protein code: crosstalk between post-translational modifications in cancer.瓜氨酸化与蛋白质编码:癌症中翻译后修饰的串扰。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220243. doi: 10.1098/rstb.2022.0243. Epub 2023 Oct 2.
8
The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells.没食子儿茶素没食子酸酯和达布拉非尼联合用药对甲状腺未分化癌细胞凋亡及表观遗传学事件相关基因的影响。
Med Oncol. 2022 May 23;39(5):98. doi: 10.1007/s12032-022-01688-x.
9
Endothelial PRMT5 plays a crucial role in angiogenesis after acute ischemic injury.内皮细胞 PRMT5 在急性缺血损伤后的血管生成中起着至关重要的作用。
JCI Insight. 2022 May 9;7(9):e152481. doi: 10.1172/jci.insight.152481.
10
PRMT5 regulates ovarian follicle development by facilitating translation.PRMT5 通过促进翻译来调节卵泡的发育。
Elife. 2021 Aug 27;10:e68930. doi: 10.7554/eLife.68930.
PRMT5 的过表达促进肿瘤细胞生长,并与上皮性卵巢癌不良预后相关。
J Histochem Cytochem. 2013 Mar;61(3):206-17. doi: 10.1369/0022155413475452. Epub 2013 Jan 4.
4
Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells.精氨酸甲基转移酶 5 在前列腺癌细胞的细胞质和细胞核中发挥相反的作用。
PLoS One. 2012;7(8):e44033. doi: 10.1371/journal.pone.0044033. Epub 2012 Aug 27.
5
Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.精氨酸甲基转移酶 5 是一种潜在的癌蛋白,可上调 G1 周期蛋白/细胞周期依赖性激酶和磷脂酰肌醇 3-激酶/AKT 信号级联。
Cancer Sci. 2012 Sep;103(9):1640-50. doi: 10.1111/j.1349-7006.2012.02367.x. Epub 2012 Aug 8.
6
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells.精氨酸甲基转移酶 5 对于肺癌细胞的生长是必需的。
Biochem J. 2012 Sep 1;446(2):235-41. doi: 10.1042/BJ20120768.
7
miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients.miR-181b 通过靶向 p27 促进肝星状细胞增殖,并且在肝硬化患者的血清中升高。
Biochem Biophys Res Commun. 2012 Apr 27;421(1):4-8. doi: 10.1016/j.bbrc.2012.03.025. Epub 2012 Mar 13.
8
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
9
Protein arginine methyltransferase 5 (PRMT5) signaling suppresses protein kinase Cδ- and p38δ-dependent signaling and keratinocyte differentiation.蛋白质精氨酸甲基转移酶 5(PRMT5)信号抑制蛋白激酶 Cδ 和 p38δ 依赖性信号传导和角质形成细胞分化。
J Biol Chem. 2012 Mar 2;287(10):7313-23. doi: 10.1074/jbc.M111.331660. Epub 2011 Dec 23.
10
Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.蛋白质精氨酸甲基转移酶 5 通过 CRAF 调节 ERK1/2 信号转导幅度和细胞命运。
Sci Signal. 2011 Sep 13;4(190):ra58. doi: 10.1126/scisignal.2001936.